Breast Cancer Risk in Primary Care
Open Access
- 27 September 2004
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 164 (17) , 1897-1903
- https://doi.org/10.1001/archinte.164.17.1897
Abstract
For the past 30 years, clinicians have used screening with mammography and breast examination as the primary approach for control of breast cancer. Despite the important role of screening, randomized trials document its modest effect on breast cancer mortality.1,2 New evidence suggests consideration of another approach: chemoprevention of breast cancer with selective estrogen receptor modulators.This publication has 10 references indexed in Scilit:
- Estimates of the Number of U.S. Women Who Could Benefit From Tamoxifen for Breast Cancer ChemopreventionJNCI Journal of the National Cancer Institute, 2003
- Chemoprevention of Breast Cancer: A Summary of the Evidence for the U.S. Preventive Services Task ForceAnnals of Internal Medicine, 2002
- Serum Estradiol Level and Risk of Breast Cancer During Treatment With RaloxifeneJAMA, 2002
- Validation of the Gail et al. Model of Breast Cancer Risk Prediction and Implications for ChemopreventionJNCI Journal of the National Cancer Institute, 2001
- Weighing the Risks and Benefits of Tamoxifen Treatment for Preventing Breast CancerJNCI Journal of the National Cancer Institute, 1999
- Validation Studies for Models Projecting the Risk of Invasive and Total Breast Cancer IncidenceJNCI Journal of the National Cancer Institute, 1999
- American Society of Clinical Oncology Technology Assessment on Breast Cancer Risk Reduction Strategies: Tamoxifen and RaloxifeneJournal of Clinical Oncology, 1999
- Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 StudyJNCI Journal of the National Cancer Institute, 1998
- Cost-Effectiveness of Extending Screening Mammography Guidelines To Include Women 40 to 49 Years of AgeAnnals of Internal Medicine, 1997
- Projecting Individualized Probabilities of Developing Breast Cancer for White Females Who Are Being Examined AnnuallyJNCI Journal of the National Cancer Institute, 1989